Global Ultomiris Drug Market Size, Share, and COVID-19 Impact Analysis, By Indication (Paroxysmal Nocturnal Hemoglobinuria, Atypical Hemolytic Uremic Syndrome, Generalized Myasthenia Gravis, and Neuromyelitis Optica Spectrum Disorder), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By End Use (Adult and Pediatric), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035.
Premium Report Details
Base Year:
2024
Tables & Figures:
100
Pages:
203
Countries covered:
20
Companies covered::
17
Forecast CAGR:
28.13%
Connect with us
smartphone
smartphone
email
email
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we
also
use cookies to show you personalized ads? Learn
more and manage your cookies